Railway Pension Investments Ltd Reduces Holdings in Stryker Corporation $SYK

Railway Pension Investments Ltd trimmed its stake in Stryker Corporation (NYSE:SYK) by 16.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,720 shares of the medical technology company’s stock after selling 82,040 shares during the quarter. Stryker makes up 1.6% of Railway Pension Investments Ltd’s portfolio, making the stock its 26th biggest holding. Railway Pension Investments Ltd’s holdings in Stryker were worth $128,367,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Brighton Jones LLC raised its holdings in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after purchasing an additional 609 shares during the period. Schnieders Capital Management LLC. acquired a new position in Stryker during the second quarter valued at approximately $205,000. Marshall Wace LLP increased its position in shares of Stryker by 107.9% in the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock worth $2,255,000 after acquiring an additional 77,831 shares in the last quarter. Nebula Research & Development LLC purchased a new position in shares of Stryker in the 2nd quarter valued at $219,000. Finally, HUB Investment Partners LLC purchased a new stake in Stryker during the 2nd quarter worth $253,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Debra King sold 826 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the transaction, the insider directly owned 6,210 shares in the company, valued at approximately $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 300,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the sale, the director owned 2,301,375 shares in the company, valued at approximately $773,031,862.50. This represents a 11.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 351,267 shares of company stock valued at $118,197,701. 4.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on SYK. Barclays dropped their price target on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Stryker in a research report on Friday, July 31st. Royal Bank Of Canada cut their price target on Stryker from $435.00 to $420.00 and set an “outperform” rating on the stock in a research note on Friday, July 31st. Argus set a $370.00 price objective on Stryker in a research note on Thursday, July 9th. Finally, BMO Capital Markets began coverage on Stryker in a research report on Wednesday, July 8th. They issued an “outperform” rating and a $369.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Stryker Trading Down 1.9%

Shares of NYSE SYK opened at $324.32 on Tuesday. The stock has a market capitalization of $124.40 billion, a P/E ratio of 33.61, a PEG ratio of 2.11 and a beta of 0.76. The stock’s 50 day moving average price is $329.49 and its two-hundred day moving average price is $331.03. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $396.86.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. The company had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.Stryker’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s payout ratio is 36.48%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.